2019 Speakers

 

Key Speakers

Shinya Yamanaka, Director of CiRA (Center for iPS Cell Research and Application), Kyoto University Shinya Yamanaka
Director of CiRA (Center for iPS Cell Research and Application)
Kyoto University

Kathy High, President and Head of R&D, Spark Therapeutics Kathy High
President and Head of R&D
Spark Therapeutics 

James Miskin, CTO, Oxford Biomedica James Miskin
CTO
Oxford Biomedica 

Andrew Obenshain, SVP, Head of Europe, bluebird bio Andrew Obenshain
SVP, Head of Europe
bluebird bio 

Andre Choulika, CEO, Cellectis Andre Choulika
CEO
Cellectis

Pascal Touchon, Senior Vice President, Global Head, Cell and Gene, Novartis Pharma Pascal Touchon
Senior Vice President, Global Head, Cell and Gene
Novartis Pharma

Bob Smith, SVP, Global Gene Therapy Business, Rare Disease, Global Innovative Pharma, Pfizer Bob Smith
SVP, Global Gene Therapy Business, Rare Disease, Global Innovative Pharma
Pfizer

Alan K. Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals Alan K. Smith
Executive Vice President, Technical Operations
Bellicum Pharmaceuticals

 
 

All Speakers

Mohamed Abou El Enein, Head of Department, Charite Universitatsmedizin

Mohamed Abou El Enein at World Advanced Therapies & Regenerative Medicine Congress 2019

Evren Alici, Assistant Professor and Group Leader, Haematology, Karolinska Institutet

Jane Andrews, Senior Director of Strategic Marketing, BioBridge Global

Jane Andrews at World Advanced Therapies & Regenerative Medicine Congress 2019

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo at World Advanced Therapies & Regenerative Medicine Congress 2019

Stephen Badylak, Deputy Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh

Tomasz Baran, Board Member, PBKM/FamiCord Group

Tomasz Baran at World Advanced Therapies & Regenerative Medicine Congress 2019

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Jacqueline Barry at World Advanced Therapies & Regenerative Medicine Congress 2019

Shirley Bartido, Director of Regulatory Affairs, Cellectis

Dr Roy Baynes, SVP & Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Robert Beckman, Managing Partner, The Channel Group, LLC

Robert Beckman at World Advanced Therapies & Regenerative Medicine Congress 2019

Tim Bertram, CEO, inRegen

Martin Birchall, Professor of Laryngology, UCL

Jaap Boelens, Haemato Oncologist, UMC Utrecht

Jaap Boelens at World Advanced Therapies & Regenerative Medicine Congress 2019

Cristiana Boi, Researcher, University of Bologna

Cristiana Boi at World Advanced Therapies & Regenerative Medicine Congress 2019

Greg Bonfiglio, Managing Director, Proteus Venture Partners

Abhijit Bopardikar, Director, ReeLabs

Abhijit Bopardikar at World Advanced Therapies & Regenerative Medicine Congress 2019

Brian Bronk, Head of External Innovation, Rare Diseases, Sanofi

Brian Bronk at World Advanced Therapies & Regenerative Medicine Congress 2019

John Campbell, Professor and Associate Director, Scottish National Blood Transfusion Service

John Campbell at World Advanced Therapies & Regenerative Medicine Congress 2019

Manuel Carrondo, Vice President, iBET ? Instituto de Biologia Experimental e Tecnológica

Manuel Carrondo at World Advanced Therapies & Regenerative Medicine Congress 2019

Ben Carter, Chief Technology Officer, CytoSeek

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Dr Andre Choulika, Chairman & Chief Executive Officer, Cellectis

Joana Correia, Executive Director and CSO, Exogenus Therapeutics

David Courtman, Chief Scientific Officer, Northern Therapeutics Inc

Maria Craig, Professor of Paediatric Endocrinology, The University of Sydney

Danielle Curfs, Program Manager Biomedical, Chemelot InSciTe

Cherie Daly, Vice President, Medical Affairs, Celularity

Davide Danovi, Director, HipSci Cell Phenotyping Programme, King's College London

Davide Danovi at World Advanced Therapies & Regenerative Medicine Congress 2019

Francesco Dazzi, Professor of Regenerative and Hematological Medicine, King's College London

Dr Robert Deans, CTO, Blue Rock Therapeutics

Dr Robert Deans at World Advanced Therapies & Regenerative Medicine Congress 2019

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Simone Dimartino, Lecturer, Institute for Bioengineering, University of Edinburgh

Jeff Drew, CSO, Cells4Life Group LLP

Dominik Egger, Research Associate, University of Natural Resources and Life Sciences

Dominik Egger at World Advanced Therapies & Regenerative Medicine Congress 2019

Jim Fackler, Associate Professor of Anesthesiology and Critical Care Medicine, John Hopkins School Of Medicine

Jim Fackler at World Advanced Therapies & Regenerative Medicine Congress 2019

Prof Farzin Farzaneh, Professor of Molecular Medicine, King's College Hospital NHS Trust

Lucy Foely, Director of biologics, The Centre For Process Innovation (CPI)

Lucy Foely at World Advanced Therapies & Regenerative Medicine Congress 2019

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy

Michela Gabaldo, Head of Alliance Management, Fondazione Telethon

Daniel Gibson, Head of Innovation and commercialation, Anthony Nolan

Daniel Gibson at World Advanced Therapies & Regenerative Medicine Congress 2019

Dan Grant, CEO, MTP Connect

Lise Marie Grav, Postdoc, Technical University of Denmark

Adam Gridley, President & CEO, Histogenics Corporation

Adam Gridley at World Advanced Therapies & Regenerative Medicine Congress 2019

Uta Griesenbach, Professor Of Molecular Medicine, Imperiai College London

Pascale Guillot, Senior Lecturer of Fetal and Maternal Health, University College London

Pascale Guillot at World Advanced Therapies & Regenerative Medicine Congress 2019

Thomas Hach, Senior Global Health Advisor, Novartis

Joshua Hare, Director of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Hansjörg Hauser, Head of Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Hansjörg Hauser at World Advanced Therapies & Regenerative Medicine Congress 2019

Frank Hecht, Vice President Marketing and Sales, CellGenix GmbH

Frank Hecht at World Advanced Therapies & Regenerative Medicine Congress 2019

Diana Hernandez, Anthony Nolan

Shay Hershcovich, Head of Business Development, Betalin Therapeutics

Kathy High, President and Head, Research & Development, Spark Therapeutics

Edward Hodgkin, Partner, Syncona Partners

Dr Ian Hudson, Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency

Dr Ian Hudson at World Advanced Therapies & Regenerative Medicine Congress 2019

Michael Hunt, Chief Executive Officer, ReNeuron Group Plc

Michael Hunt at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Dr Moshe Israeli at World Advanced Therapies & Regenerative Medicine Congress 2019

Zoran Ivanovic, Scientific Director, French Blood Institute Aquitaine Limousin Branch

Dmitrii Ivolgin, Medical Director, Stem Cells Bank Pokrovski

Audrey Jamieson, Business Development Manager, The Clinical Trial Company Limited

Audrey Jamieson at World Advanced Therapies & Regenerative Medicine Congress 2019

Agnieszka Janeczek, Interim CEO, Renovos

Agnieszka Janeczek at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Bo Kara, Head Process Development, GlaxoSmithKline

Ohad Karnieli, Chief Executive Officer and Co Founder, Atvio Biotechnology

Ohad Karnieli at World Advanced Therapies & Regenerative Medicine Congress 2019

Cornelia Kasper, Professor, Biopharmaceutical Production and Technology, B.O.K.U.

Cornelia Kasper at World Advanced Therapies & Regenerative Medicine Congress 2019

Hans Keirstead, Chief Executive Officer,, AiVita Biomedical

Aisha Khan, Executive Director of Laboratory Operations, Interdisciplinary Stem Cell Institute

Aisha Khan at World Advanced Therapies & Regenerative Medicine Congress 2019

Sven Kili, Vice President and Head of Gene Therapy Development, Sven Kili Consulting

Sven Kili at World Advanced Therapies & Regenerative Medicine Congress 2019

Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics

Wolfgang Knirsch, CEO, Vita34

Wolfgang Knirsch at World Advanced Therapies & Regenerative Medicine Congress 2019

James Kovach, Director, Innovation

James Kovach at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Dr Joanne Kurtzberg at World Advanced Therapies & Regenerative Medicine Congress 2019

Dmitry Kuzmin, Managing Partner, 4Bio Capital

Jean-Pierre Latere, COO, Celyad

Jean-Pierre Latere at World Advanced Therapies & Regenerative Medicine Congress 2019

Katarina Le Blanc, Professor/Specialist Physician, Division of Clinical Immunology, Karolinska Institutet

Katarina Le Blanc at World Advanced Therapies & Regenerative Medicine Congress 2019

Jane Lebkowski, President of Research and Development, Regenerative Patch Technologies

Jane Lebkowski at World Advanced Therapies & Regenerative Medicine Congress 2019

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Chaim Lebovits at World Advanced Therapies & Regenerative Medicine Congress 2019

Dave Lennon, President, AveXis Inc

Dave Lennon at World Advanced Therapies & Regenerative Medicine Congress 2019

Giovanna Lombardi, Professor of Human Transplant Immunobiology, King's College London

Giovanna Lombardi at World Advanced Therapies & Regenerative Medicine Congress 2019

Douglas Losordo, Chief Medical Officer, Caladrius

Douglas Losordo at World Advanced Therapies & Regenerative Medicine Congress 2019

Mark Lowdell, Director of Cellular Therapy, Royal Free London NHS Foundation Trust

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

Dr Danilo Maddalo at World Advanced Therapies & Regenerative Medicine Congress 2019

John Maher, Chief Scientific Officer, Leucid Bio

John Maher at World Advanced Therapies & Regenerative Medicine Congress 2019

Rachel Manley, Head of Global Outreach, Save the Cord Foundation

Rachel Manley at World Advanced Therapies & Regenerative Medicine Congress 2019

Marcello Maresca, Associate Director, Astrazeneca Ab

Dr Irene Martini, Lecturer, University La Sapienza

Dr Irene Martini at World Advanced Therapies & Regenerative Medicine Congress 2019

Irene Mavroudi, Researcher, Public Cord Blood Bank of Crete

Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

Giuseppe Mazza at World Advanced Therapies & Regenerative Medicine Congress 2019

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Ian Mckay, ‎Innovation Lead Advanced Therapies, Innovate UK

Ian Mckay at World Advanced Therapies & Regenerative Medicine Congress 2019

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf at World Advanced Therapies & Regenerative Medicine Congress 2019

Stefano Menegatti, Assistant Professor in Chemical and Biomolecular Engineering, North Carolina State University

Stefano Menegatti at World Advanced Therapies & Regenerative Medicine Congress 2019

Annamaria Merico, Head of Technology Transfer, Fondazione Telethon

Annamaria Merico at World Advanced Therapies & Regenerative Medicine Congress 2019

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr James Miskin, Chief Technical Officer, Oxford BioMedica

Claudia Mitchell, Chief Executive Officer, Universal Cells

Claudia Mitchell at World Advanced Therapies & Regenerative Medicine Congress 2019

Neill Moray Mackenzie, Chairman & Board Mamber, Cellular Therapeutics Ltd

Neill Moray Mackenzie at World Advanced Therapies & Regenerative Medicine Congress 2019

David Morrow, Project Manager, EATRIS

David Morrow at World Advanced Therapies & Regenerative Medicine Congress 2019

Sue Mundy, Head of Cord Blood Collection, Anthony Nolan

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy at World Advanced Therapies & Regenerative Medicine Congress 2019

Prof Norio Nakatsuji, Chief Advisor, Kyoto University

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Josefina Nilsson, Head of Business Unit, Vironova

Andrew Obenshain, Senior Vice President And Head Of Europe, Bluebird Bio

Jelena Ochs, Head of the Business Unit for Life Sciences Engineering, Fraunhofer Institute for Production Technology

Jelena Ochs at World Advanced Therapies & Regenerative Medicine Congress 2019

Dominic O'Reagan, Director & Investor, New Mosaic

Felicia Pagliuca, Co-founder and VP, Cell Biology R&D, Semma Therapeutics

Helen Papadaki, Professor of Haematology, School of Medicine, University of Crete, Head of the Department of Haematology, Public Cord Blood Bank of Crete

Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven

Ioannis Papantoniou at World Advanced Therapies & Regenerative Medicine Congress 2019

Guy Parkes, Head of Stem Cell Donation, N.H.S. Blood and Transplant

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Detlev Parow at World Advanced Therapies & Regenerative Medicine Congress 2019

Vivienne Parry, Head of Engagement, Genomics England

Vivienne Parry at World Advanced Therapies & Regenerative Medicine Congress 2019

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Amnon Pelz, CEO, Taburit

Amnon Pelz at World Advanced Therapies & Regenerative Medicine Congress 2019

Sergey Piletsky, Professor, University of Leicester

Sergey Piletsky at World Advanced Therapies & Regenerative Medicine Congress 2019

Govind Pindoria, Translational R and D Manager, Imperial Innovations

Dr Nicolas Pineault, Development Scientist, Canadian Blood Services

Sarah Haywood Price, Chief Executive Officer, MedCity

Dr Qasim Rafiq, Associate Professor, Bioprocessing of Cell and Gene Therapies, University College London

Dr Qasim Rafiq at World Advanced Therapies & Regenerative Medicine Congress 2019

Kavita Raj, Consultant Haematologist, Guy's And St Thomas' Hospital

Kavita Raj at World Advanced Therapies & Regenerative Medicine Congress 2019

Ajan Reginald, CEO, Celixir

Katy Rezvani, Chief, Section of Cellular Therapy, MD Anderson Cancer Center

Katy Rezvani at World Advanced Therapies & Regenerative Medicine Congress 2019

Mike Rice, Principal, Defined Health

Rodney Rietze, Lead CGMP Process Automation, Novartis

Dr Barry Rosen, Senior Principal Scientist/Director, AstraZeneca

Dr Barry Rosen at World Advanced Therapies & Regenerative Medicine Congress 2019

Joseph Rotino, Vice President, Quality Assurance and Regulatory Affairs, Cryoport Inc

Mark Sawicki, Chief Commercial Officer, Cryoport Inc

Katja Schmidt, Head Market Access Oncology,, Novartis

Katja Schmidt at World Advanced Therapies & Regenerative Medicine Congress 2019

Beth Shaz, Chief Medical Officer, New York Blood Center

Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network

Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo

Benjamin Shepherd at World Advanced Therapies & Regenerative Medicine Congress 2019

Elizabeth Shpall, Director, MD Anderson Cancer Center

Elizabeth Shpall at World Advanced Therapies & Regenerative Medicine Congress 2019

David Sloman, Chief Executive Officer, Royal Free London NHS Foundation Trust

David Sloman at World Advanced Therapies & Regenerative Medicine Congress 2019

Devyn Smith, Chief Operations Officer And Head Of Strategy, Sigilon

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Eric Soller at World Advanced Therapies & Regenerative Medicine Congress 2019

Susan Solomon, Chief Executive Officer and Co-Founder, New York Stem Cell Foundation

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Sanja Stifter Md, Phd, Professor, Department of Pathology, Faculty of Medicine, University of Rijeka

Corné Swart, Head of Business Development, Cellbox Solutions

Corné Swart at World Advanced Therapies & Regenerative Medicine Congress 2019

Stefanos Theoharis, Senior Vice President of Corporate Development and Partnering, Cell Medica Ltd

Stefanos Theoharis at World Advanced Therapies & Regenerative Medicine Congress 2019

Robert Thomas, EPSRC Career Fellow, EPSRC Centre for Innovative Manufacturing in Regenerative Medicine, Loughborough University

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Marc Turner at World Advanced Therapies & Regenerative Medicine Congress 2019

Alain Vertes, Vice President, Alliance Management, Mesoblast Inc

Alain Vertes at World Advanced Therapies & Regenerative Medicine Congress 2019

Rogerio Vivaldi, CEO, Sigilon Therapeutics

Rogerio Vivaldi at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Ivan Wall, Reader in Department of Biochemical Engineering, Aston University

Dr Ivan Wall at World Advanced Therapies & Regenerative Medicine Congress 2019

Dr Michael West, Chief Executive Officer, AgeX Therapeutics

Dr Michael West at World Advanced Therapies & Regenerative Medicine Congress 2019

Mathew Wheeler, Associate Director of Europe, VectorBuilder

Michal Wlodarski, Principal, Cambridge Innovation Consulting

David Johannes Wurm, Project Assistant of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm at World Advanced Therapies & Regenerative Medicine Congress 2019

Shinya Yamanaka, Director and Professor, Center for iPS Cell Research & Application (CiRA), Kyoto University

Stefano Zancan, Head Clinical Development and Operations, Fondazione Telethon

Dr Mark Zimmerman, Vice President, Business Development and Strategy, ViaCyte

Dr Mark Zimmerman at World Advanced Therapies & Regenerative Medicine Congress 2019
 

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com